Canaccord Genuity Upgrades Progyny to Buy, Raises Price Target to $30

Benzinga Newsdesk www.benzinga.com Positive 80.3%

Neg 0% Neu 0% Pos 80.3%

Canaccord Genuity analyst Richard Close upgrades Progyny (NASDAQ:PGNY) from Hold to Buy and raises the price target from $19 to $30.